日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ageing promotes metastasis via activation of the integrated stress response

衰老通过激活整合应激反应促进转移。

Patel, Angana A H; Dzanan, Jozefina J; Ali, Kevin X; Eklund, Ella A; Alvarez, Samantha W; Raj, Dorota; Dankis, Martin; Altinönder, Ilayda; Schwarz, Maria; Le Gal, Kristell; Bedel, Emre; El Zowalaty, Ahmed Ezat; Jonasson, Emma; Albatrok, Heba; Gul, Nadia; Bossowski, Jozef P; Pillai, Ray; Micke, Patrick; Botling, Johan; Akyürek, Levent M; Angeletti, Davide; Sayin, Sama I; Härtlova, Anetta; Papagiannakopoulos, Thales; Olofsson Bagge, Roger; Ståhlberg, Anders; Hallqvist, Andreas; Wiel, Clotilde; Sayin, Volkan I

Nuclear AGO2 supports influenza A virus replication through type-I interferon regulation.

核内 AGO2 通过 I 型干扰素调节支持甲型流感病毒复制

Huang Hsiang-Chi, Fong Michelle, Nowak Iwona, Shcherbinina Evgeniia, Lobo Vivian, Besavilla Danica F, Huynh Hang T, Schön Karin, Westholm Jakub O, Fernandez Carola, Patel Angana A H, Wiel Clotilde, Sayin Volkan I, Anastasakis Dimitrios G, Angeletti Davide, Sarshad Aishe A

Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer

全面的基因变异分析揭示KRAS和LRP1B的组合可作为非小细胞肺癌患者免疫治疗反应的预测性生物标志物

Eklund, Ella A; Svensson, Johanna; Näslund, Louise Stauber; Yhr, Maria; Sayin, Sama I; Wiel, Clotilde; Akyürek, Levent M; Torstensson, Per; Sayin, Volkan I; Hallqvist, Andreas; Raghavan, Sukanya; Rohlin, Anna

Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitors.

鉴定 BACH1 肺癌特征:了解 BACH1 生物学和鉴定新抑制剂的新工具

Klenja-Skudrinja Donika, Ali Kevin X, Walker David, Higgins Maureen, Patel Angana Ah, Raj Dorota, Creelman Anna, McDowall Charlotte, Taylor Conor, Wenta Tomasz, Larsson Erik, Wiel Clotilde, Sayin Volkan I, de la Vega Laureano

BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAF(V600E)-induced hepatocellular carcinoma

BRAF抑制剂可增加TGFβ2的产生,并刺激内源性BRAF(V600E)诱导的肝细胞癌小鼠的转移。

Cisowski, Jaroslaw; El Zowalaty, Ahmed Ezat; Sayin, Sama I; Czarnota, Piotr; Gromowski, Tomasz; Eklund, Ella A; Kashif, Muhammad; Patel, Angana A H; Molinaro, Antonio; Lindahl, Per; Wiel, Clotilde; Sayin, Volkan I; Bergo, Martin O

Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish Cohort

免疫检查点阻断单药治疗可改善KRAS突变型而非KRAS野生型转移性肺腺癌患者的生存结局:来自瑞典扩展队列的验证

Eklund, Ella A; Sayin, Sama I; Jonsson, Jonas Smith; van Renswoude, Hannes; Nyman, Jan; Hallqvist, Andreas; Wiel, Clotilde; Sayin, Volkan I

Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis

转移性器官趋向性差异影响肺腺癌脑转移的预后

Sayin, Sama I; Eklund, Ella A; Ali, Kevin X; Dzanan, Jozefina J; Xylander, Moe; Dankis, Martin; Lindahl, Per; Sayin, Volkan I; Hallqvist, Andreas; Wiel, Clotilde

Brain metastasis in stage IV lung adenocarcinoma is frequently missed by symptom-based screening

IV期肺腺癌脑转移常常被基于症状的筛查漏诊。

Sayin, Sama I; Eklund, Ella A; Beischer, Moa; Moe, Torill; Ali, Kevin X; Gunnarsson, Kerstin; Xylander, Moe; Ny, Lars; Jakola, Asgeir S; Häggström, Ida; Wiel, Clotilde; Hallqvist, Andreas; Sayin, Volkan I

Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis

评估KRAS突变联合肿瘤大小对I-II期非小细胞肺癌预后价值的回顾性分析

Eklund, Ella A; Mourad, Ali; Wiel, Clotilde; Sayin, Sama I; Fagman, Henrik; Hallqvist, Andreas; Sayin, Volkan I

SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity

SOX9驱动KRAS诱导的肺腺癌进展并抑制抗肿瘤免疫

Zhong, Hua; Lu, Wen; Tang, Yong; Wiel, Clotilde; Wei, Yong; Cao, Jian; Riedlinger, Gregory; Papagiannakopoulos, Thales; Guo, Jessie Yanxiang; Bergo, Martin O; Kang, Yibin; Ganesan, Shridar; Sabaawy, Hatim E; Pine, Sharon R